Wako HCC Biomarker(s) DCP and AFP-L3: payments to doctors
Payments that named Wako HCC Biomarker(s) DCP and AFP-L3 as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $20K
- Providers
- 81
- Transactions
- 105
- Average per transaction
- $190
The per-transaction average — $190 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 81 providers the average total is $246, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Fujifilm Wako Diagnostics U.S.A. Corporation | $14,099 | 70.8% |
| Fujifilm Medical Systems USA, Inc. | $5,824 | 29.2% |